The Analysis of the efficacy and efficiency of carbon dioxide fractional laser cosmetic treatment of skin diseases

Abstract

This study evaluates the application value of carbon dioxide fractional laser cosmetology in the treatment of dermatological diseases, focusing on its therapeutic effects, scar remaining rate, pain scores, lesion counts, and wound granulation status. A total of 74 patients with dermatological disorders were randomly assigned to an experimental group and a control group from May 2023 to May 2024. The experimental group received carbon dioxide fractional laser treatment, while the control group was treated with conventional medication. The results indicated that the experimental group had higher therapeutic effects (97.30% vs. 78.38%, P < 0.05), a lower scar remaining rate (2.70% vs. 24.32%, P < 0.05), and significantly reduced pain scores post-treatment (P < 0.05). Additionally, the experimental group showed a decrease in lesion counts and improved wound granulation status compared to the control group. The study concludes that carbon dioxide fractional laser treatment is an effective and less painful method for treating dermatological diseases, with advantages such as non-invasiveness, short recovery time, and minimal side effects. The technology's precision, ability to stimulate collagen production, and promote skin remodeling contribute to its efficacy in improving skin quality and treating skin diseases. The study supports the further development and optimization of carbon dioxide fractional laser technology for safer and more effective dermatological treatments.